These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
615 related articles for article (PubMed ID: 21566055)
1. Anti-phospholipase A2 receptor antibody in membranous nephropathy. Qin W; Beck LH; Zeng C; Chen Z; Li S; Zuo K; Salant DJ; Liu Z J Am Soc Nephrol; 2011 Jun; 22(6):1137-43. PubMed ID: 21566055 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases. Radice A; Pieruzzi F; Trezzi B; Ghiggeri G; Napodano P; D'Amico M; Stellato T; Brugnano R; Ravera F; Rolla D; Pesce G; Giovenzana ME; Londrino F; Cantaluppi V; Pregnolato F; Volpi A; Rombolà G; Moroni G; Ortisi G; Sinico RA J Nephrol; 2018 Apr; 31(2):271-278. PubMed ID: 29081027 [TBL] [Abstract][Full Text] [Related]
3. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy. Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555 [TBL] [Abstract][Full Text] [Related]
4. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Svobodova B; Honsova E; Ronco P; Tesar V; Debiec H Nephrol Dial Transplant; 2013 Jul; 28(7):1839-44. PubMed ID: 23223223 [TBL] [Abstract][Full Text] [Related]
5. Circulating antibodies to α-enolase and phospholipase A Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547 [TBL] [Abstract][Full Text] [Related]
6. Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy. Wang J; Cui Z; Lu J; Probst C; Zhang YM; Wang X; Qu Z; Wang F; Meng LQ; Cheng XY; Liu G; Debiec H; Ronco P; Zhao MH Clin J Am Soc Nephrol; 2017 Oct; 12(10):1642-1651. PubMed ID: 28801527 [TBL] [Abstract][Full Text] [Related]
7. Anti-PLA2R Antibodies in Chinese Patients with Membranous Nephropathy. Li X; Wei D; Zhou Z; Wang B; Xu Y; Pan J; Yang C; Lu J; Qiu Y Med Sci Monit; 2016 May; 22():1630-6. PubMed ID: 27179439 [TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN). Radice A; Trezzi B; Maggiore U; Pregnolato F; Stellato T; Napodano P; Rolla D; Pesce G; D'Amico M; Santoro D; Londrino F; Ravera F; Ortisi G; Sinico RA Autoimmun Rev; 2016 Feb; 15(2):146-54. PubMed ID: 26527329 [TBL] [Abstract][Full Text] [Related]
9. Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy. Zhang Q; Huang B; Liu X; Liu B; Zhang Y; Zhang Z; Hua J; Fan Y; Hu L; Meng M; Wu M; Wang L; Hu Z; Sun Z Sci Rep; 2017 Sep; 7(1):12049. PubMed ID: 28935926 [TBL] [Abstract][Full Text] [Related]
10. Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy. Liu L; Chang B; Wu X; Guo Y; Pan Y; Yang L Vasc Health Risk Manag; 2018; 14():103-108. PubMed ID: 29881283 [TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods. Katsumata Y; Okamoto Y; Moriyama T; Moriyama R; Kawamoto M; Hanaoka M; Uchida K; Nitta K; Harigai M Immunol Med; 2020 Mar; 43(1):47-56. PubMed ID: 31910103 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers to detect membranous nephropathy in Chinese patients. Lin L; Wang WM; Pan XX; Xu J; Gao CN; Zhang W; Ren H; Xie JY; Shen PY; Xu YW; Ni LY; Chen N Oncotarget; 2016 Oct; 7(42):67868-67879. PubMed ID: 27634909 [TBL] [Abstract][Full Text] [Related]
13. Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study. Zhao Y; Cai M; Jiang Z; Dong B; Yan Y; Wang Y; Zuo L Ren Fail; 2022 Dec; 44(1):428-433. PubMed ID: 35272568 [TBL] [Abstract][Full Text] [Related]
14. Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China. Guo N; Cao Y; Dai H; Yuan L; Shi L; Zhang Y Med Sci Monit; 2019 Dec; 25():9364-9368. PubMed ID: 31813930 [TBL] [Abstract][Full Text] [Related]
15. Anti-Phospholipase A2 Receptor Antibody as Prognostic Indicator in Idiopathic Membranous Nephropathy. Kim YG; Choi YW; Kim SY; Moon JY; Ihm CG; Lee TW; Jeong KH; Yang SH; Kim YS; Oh YJ; Lee SH Am J Nephrol; 2015; 42(3):250-7. PubMed ID: 26484659 [TBL] [Abstract][Full Text] [Related]
16. Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy. Xie Q; Li Y; Xue J; Xiong Z; Wang L; Sun Z; Ren Y; Zhu X; Hao CM Am J Nephrol; 2015; 41(4-5):345-53. PubMed ID: 26087695 [TBL] [Abstract][Full Text] [Related]
19. Definition of a new cut-off for the anti-phospholipase A2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy. Tampoia M; Migliucci F; Villani C; Abbracciavento L; Rossini M; Fumarulo R; Gesualdo L; Montinaro V J Nephrol; 2018 Dec; 31(6):899-905. PubMed ID: 30187382 [TBL] [Abstract][Full Text] [Related]
20. Sjögren's syndrome complicated with membranous nephropathy, a cause or coincidence? Chen R; Wang J; Xie Q; Xue J; Hao C Int J Rheum Dis; 2021 Aug; 24(8):1086-1094. PubMed ID: 34223708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]